...
首页> 外文期刊>Journal of genetic counseling >Feasibility of an Assessment Tool for Children's Competence to Consent to Predictive Genetic Testing: a Pilot Study
【24h】

Feasibility of an Assessment Tool for Children's Competence to Consent to Predictive Genetic Testing: a Pilot Study

机译:儿童同意接受预测性基因测试能力的评估工具的可行性:一项初步研究

获取原文
获取原文并翻译 | 示例
           

摘要

Knowledge on children's capacities to consent to medical treatment is limited. Also, age limits for asking children's consent vary considerably between countries. Decision-making on predictive genetic testing (PGT) is especially complicated, considering the ongoing ethical debate. In order to examine just age limits for alleged competence to consent in children, we evaluated feasibility of a standardized assessment tool, and investigated cutoff ages for children's competence to consent to PGT. We performed a pilot study, including 17 pediatric outpatients between 6 and 18 years at risk for an autosomal dominantly inherited cardiac disease, eligible for predictive genetic testing. The reference standard for competence was established by experts trained in the relevant criteria for competent decision-making. The MacArthur Competence Assessment Tool for Treatment (MacCAT-T) served as index test. Data analysis included raw agreement between competence classifications, difference in mean ages between children judged competent and judged incompetent, and estimation of cutoff ages for judgments of competence. Twelve (71 %) children were considered competent by the reference standard, and 16 (94 %) by the MacCAT-T, with an overall agreement of 76 %. The expert judgments disagreed in most cases, while the MacCAT-T judgments agreed in 65 %. Mean age of children judged incompetent was 9.3 years and of children judged competent 12.1 years (p = .035). With 90 % sensitivity, children younger than 10.0 years were judged incompetent, with 90 % specificity children older than 11.8 years were judged competent. Feasibility of the MacCAT-T in children is confirmed. Initial findings on age cutoffs are indicative for children between the age of 12 and 18 to be judged competent for involvement in the informed consent process. Future research on appropriate age-limits for children's alleged competence to consent is needed.
机译:关于儿童同意接受治疗的能力的知识是有限的。此外,各国之间征求儿童同意的年龄限制也相差很大。考虑到正在进行的伦理辩论,预测基因测试(PGT)的决策特别复杂。为了检查儿童所谓的同意能力的年龄限制,我们评估了标准化评估工具的可行性,并调查了儿童同意PGT的能力的临界年龄。我们进行了一项前瞻性研究,包括17名年龄在6至18岁之间的常染色体显性遗传性心脏病风险患者,这些患者有资格进行预测基因测试。胜任力的参考标准是由接受过有关胜任决策标准的培训的专家建立的。麦克阿瑟治疗能力评估工具(MacCAT-T)用作指标测试。数据分析包括能力分类之间的原始一致性,被判定为胜任和被判定为不胜任的孩子之间的平均年龄差异,以及评估胜任力的截止年龄。参考标准认为12名儿童(71%)能胜任,MacCAT-T认为16名儿童(94%)能胜任,总体同意率为76%。在大多数情况下,专家的判断是不同意的,而MacCAT-T的判断同意率为65%。被判为无行为能力的儿童的平均年龄为9.3岁,被判为有能力的儿童的平均年龄为12.1岁(p = .035)。敏感性为90%的儿童被判定为不称职的年龄小于10.0岁,而特异性为90%的儿童被认为是合格的,年龄大于11.8岁。确认了MacCAT-T在儿童中的可行性。年龄界限的初步发现表明,年龄在12至18岁之间的儿童被判定有能力参与知情同意程序。需要对儿童所谓的同意能力的适当年龄限制进行进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号